The Technical AnalystExchange: SIX Industry: Diversified Financials
Bellevue Group AG Price, Forecast, Insider, Ratings, Fundamentals & Signals
-2.47% CHF17.80
America/New_York / 2 mai 2024 @ 07:26
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 234.18 mill |
| EPS: | 1.150 |
| P/E: | 15.48 |
| Earnings Date: | Jul 24, 2024 |
| SharesOutstanding: | 13.16 mill |
| Avg Daily Volume: | 0.0145 mill |
| RATING 2024-05-02 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.61x |
| Company: PE 15.48 | sector: PE 25.29 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.49x |
| Company: PE 15.48 | industry: PE 10.40 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CHF33.17 (86.34%) CHF15.37 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
CHF 17.20 - 18.40 ( +/- 3.35%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CHF17.80 (-2.47% ) |
| Volume | 0.0124 mill |
| Avg. Vol. | 0.0145 mill |
| % of Avg. Vol | 85.21 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BBN.SW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BBN.SW
Bellevue Group AG provides asset management services in Switzerland, the Great Britain, Germany, and internationally. The company offers a range of products in the areas of specialized healthcare equity, selected niche, and entrepreneur strategies. It also provides various investment funds; and investment solutions for institutional, intermediary, and private clients, as well as investment advisory and research services. The company was founded in 1993 and is headquartered in Küsnacht, Switzerland.